Thus, when the amyloidogenic pathway is augmented in either familial or sporadic AD, CHCHD6 deficiency could result in MICOS disassembly, mitochondrial bioenergetic failure, cholesterol accumulation, neuropathology and cognitive deficiency in AD. Here, CHCHD6 is linked to Alzheimer disease.